FORA Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.3M Buy
756,269
+385,335
+104% +$20.9M 2.22% 1
2026
Q1
$23.3M Buy
370,934
+359,135
+3,044% +$28.7M 1.71% 1
2025
Q4
$919K Buy
+11,799
New +$1.16M 0.11% 214
2025
Q3
Sell
-3,133
Closed -$337K 500
2025
Q2
$337K Sell
3,133
-47,850
-94% -$4.84M 0.04% 389
2025
Q1
$5.14M Buy
+50,983
New +$5.13M 0.52% 50
2022
Q4
Sell
-18,778
Closed -$727K 478
2022
Q3
$727K Buy
+18,778
New +$753K 0.14% 201
2020
Q2
Sell
-34,237
Closed -$1.12M 920
2020
Q1
$1.12M Buy
+34,237
New +$1.34M 0.24% 107

Other funds holding BSX

FORA Capital's BSX Position: Q2 2026 in Review

FORA Capital increased its Boston Scientific (BSX) stake by 104% in Q2 2026, buying an estimated $20.9M and bringing the position to 756,269 shares worth $32.3M. The position accounts for 2.22% of the portfolio, ranked #1.

FORA Capital first reported a position in BSX in Q1 2020 and has held it in 7 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • FORA Capital held 756,269 shares of Boston Scientific worth $32.3M as of Q2 2026.
  • FORA Capital bought 385,335 Boston Scientific shares in Q2 2026, an estimated $20.9M.
  • Boston Scientific made up 2.22% of FORA Capital's portfolio in Q2 2026, its #1 holding.
  • FORA Capital first reported a position in Boston Scientific in Q1 2020 and has held it in 7 quarters since.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.